Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Herbalife Ltd has a consensus price target of $15.33 based on the ratings of 8 analysts. The high is $36 issued by Citigroup on May 4, 2022. The low is $8 issued by B of A Securities on March 21, 2024. The 3 most-recent analyst ratings were released by DA Davidson, DA Davidson, and Mizuho on March 21, 2025, February 20, 2025, and November 1, 2024, respectively. With an average price target of $10.17 between DA Davidson, DA Davidson, and Mizuho, there's an implied 20.17% upside for Herbalife Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
03/21/2025 | Buy Now | 65.48% | DA Davidson | Linda Bolton Weiser55% | $7.5 → $14 | Upgrade | Neutral → Buy | Get Alert |
02/20/2025 | Buy Now | -11.35% | DA Davidson | Linda Bolton Weiser55% | $7.5 → $7.5 | Maintains | Neutral | Get Alert |
11/01/2024 | Buy Now | 6.38% | Mizuho | John Baumgartner69% | $8 → $9 | Maintains | Neutral | Get Alert |
10/31/2024 | Buy Now | -11.35% | DA Davidson | Linda Bolton Weiser55% | $13 → $7.5 | Maintains | Neutral | Get Alert |
10/31/2024 | Buy Now | 41.84% | B. Riley Securities | Jeff Van Sinderen72% | $17 → $12 | Maintains | Buy | Get Alert |
10/25/2024 | Buy Now | 53.66% | Citigroup | Chasen Bender29% | $16 → $13 | Maintains | Buy | Get Alert |
08/01/2024 | Buy Now | 100.95% | B. Riley Securities | Jeff Van Sinderen72% | $16 → $17 | Maintains | Buy | Get Alert |
08/01/2024 | Buy Now | 53.66% | DA Davidson | Linda Bolton Weiser55% | $9.5 → $13 | Maintains | Neutral | Get Alert |
06/07/2024 | Buy Now | 30.02% | Mizuho | John Baumgartner69% | $10 → $11 | Maintains | Neutral | Get Alert |
05/02/2024 | Buy Now | 12.29% | DA Davidson | Linda Bolton Weiser55% | $9.5 → $9.5 | Maintains | Neutral | Get Alert |
03/25/2024 | Buy Now | 12.29% | DA Davidson | Linda Bolton Weiser55% | $11 → $9.5 | Maintains | Neutral | Get Alert |
03/21/2024 | Buy Now | -5.44% | B of A Securities | Anna Lizzul56% | $10 → $8 | Maintains | Underperform | Get Alert |
03/21/2024 | Buy Now | 18.2% | Mizuho | John Baumgartner69% | $12 → $10 | Maintains | Neutral | Get Alert |
02/16/2024 | Buy Now | 41.84% | Mizuho | John Baumgartner69% | $14 → $12 | Maintains | Neutral | Get Alert |
11/29/2023 | Buy Now | 65.48% | Mizuho | John Baumgartner69% | $17 → $14 | Maintains | Neutral | Get Alert |
09/14/2023 | Buy Now | 59.57% | DA Davidson | Linda Bolton Weiser55% | → $13.5 | Initiates | → Neutral | Get Alert |
08/03/2023 | Buy Now | 100.95% | Mizuho | John Baumgartner69% | $13 → $17 | Maintains | Neutral | Get Alert |
06/07/2023 | Buy Now | 53.66% | Mizuho | John Baumgartner69% | → $13 | Initiates | → Neutral | Get Alert |
03/01/2023 | Buy Now | 230.97% | Citigroup | Chasen Bender29% | $26 → $28 | Maintains | Buy | Get Alert |
02/03/2023 | Buy Now | 65.48% | B of A Securities | Anna Lizzul56% | → $14 | Initiates | → Underperform | Get Alert |
11/01/2022 | Buy Now | 266.43% | B. Riley Securities | Jeff Van Sinderen72% | $38 → $31 | Maintains | Buy | Get Alert |
11/01/2022 | Buy Now | 207.33% | Citigroup | Chasen Bender29% | $30 → $26 | Maintains | Buy | Get Alert |
10/05/2022 | Buy Now | 254.61% | Citigroup | Chasen Bender29% | $36 → $30 | Maintains | Buy | Get Alert |
07/12/2022 | Buy Now | — | Jefferies | Stephanie Wissink78% | — | Upgrade | Hold → Buy | Get Alert |
05/17/2022 | Buy Now | — | Argus Research | John Staszak68% | — | Downgrade | Buy → Hold | Get Alert |
05/04/2022 | Buy Now | 384.63% | B. Riley Securities | Jeff Van Sinderen72% | $50 → $41 | Maintains | Buy | Get Alert |
05/04/2022 | Buy Now | 325.53% | Citigroup | Wendy Nicholson65% | $46 → $36 | Maintains | Buy | Get Alert |
05/04/2022 | Buy Now | 207.33% | Jefferies | Stephanie Wissink78% | $60 → $26 | Downgrade | Buy → Hold | Get Alert |
The latest price target for Herbalife (NYSE:HLF) was reported by DA Davidson on March 21, 2025. The analyst firm set a price target for $14.00 expecting HLF to rise to within 12 months (a possible 65.48% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Herbalife (NYSE:HLF) was provided by DA Davidson, and Herbalife upgraded their buy rating.
The last upgrade for Herbalife Ltd happened on March 21, 2025 when DA Davidson raised their price target to $14. DA Davidson previously had a neutral for Herbalife Ltd.
The last downgrade for Herbalife Ltd happened on May 17, 2022 when Argus Research changed their price target from N/A to N/A for Herbalife Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Herbalife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Herbalife was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.
While ratings are subjective and will change, the latest Herbalife (HLF) rating was a upgraded with a price target of $7.50 to $14.00. The current price Herbalife (HLF) is trading at is $8.46, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.